Stewart Jeffrey Ryan — SEC Form 4 filings
SEC reporting owner CIK 1761675. 8 Form 4 filings on record with FilingPulse; latest filed 2026-03-03.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-20 to 2026-03-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 2 filings — 117,781 shares, $22,899,012 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 33,132 shares @ $210.54 ($6,975,611) in AbbVie Inc., filed 2025-04-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AbbVie Inc. (ABBV) | EVP, CHIEF COMMERCIAL OFFICER | 8 | — | 5 legs · 117,781 sh · $22,899,012 | 22 |
Form 4 filings — Stewart Jeffrey Ryan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-03 | 4 | AbbVie Inc. (ABBV) | Tax withholding (F): 23,812 @ $232.08 | EDGAR |
| 2026-02-20 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 26,063 @ $0 · Grant/award (A): 9,266 @ $0 · Grant/award (A): 9,432 @ $0 · Grant/award (A): 8,988 @ $0 · Grant/award (A): 26,812 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | AbbVie Inc. (ABBV) | Option exercise (M): 25,700 @ $79.02 · Sale (S): 25,700 @ $209.49 · Sale (S): 33,132 @ $210.54 · Option exercise (M): 25,700 (derivative) @ $79.02 | EDGAR |
| 2025-03-04 | 4 | AbbVie Inc. (ABBV) | Tax withholding (F): 20,226 @ $205.02 | EDGAR |
| 2025-02-18 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 19,111 @ $0 · Grant/award (A): 7,840 @ $0 · Grant/award (A): 9,268 @ $0 · Grant/award (A): 9,432 @ $0 · Grant/award (A): 33,854 (derivative) @ $0 | EDGAR |
| 2024-03-20 | 4 | AbbVie Inc. (ABBV) | Option exercise (M): 26,110 @ $61.36 · Sale (S): 26,110 @ $178.85 · Sale (S): 5,099 @ $179.03 · Sale (S): 27,740 @ $178.69 · Option exercise (M): 26,110 (derivative) @ $61.36 | EDGAR |
| 2024-03-01 | 4 | AbbVie Inc. (ABBV) | Tax withholding (F): 26,121 @ $178.99 | EDGAR |
| 2024-02-20 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 33,042 @ $0 · Grant/award (A): 8,810 @ $0 · Grant/award (A): 7,840 @ $0 · Grant/award (A): 9,268 @ $0 · Grant/award (A): 39,085 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1761675 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →